LGALS13 Antikörper (AA 23-134) (Biotin)

Produktnummer ABIN6189451

Produktdetails anti-LGALS13 Antikörper (Biotin)

Target: LGALS13 (Lectin, Galactoside-Binding, Soluble, 13 (LGALS13))

Bindungsspezifität: AA 23-134

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser LGALS13 Antikörper ist konjugiert mit Biotin

Applikation: Flow Cytometry (FACS), Immunofluorescence (IF), Immunohistochemistry (IHC), ELISA, Coating (Coat)

Verwendungszweck: Mouse Monoclonal anti-Galectin-13 / Placental-Protein-13 (PP13/1162), Biotin Conjugate

Produktmerkmale: This antibody recognizes a 32 kDa protein, which is identified as homodimer of galectin-13 (also known as PP13). Galectins are a family of soluble ?-galactoside-binding lectins that modulate cell-to-cell adhesion and cell-to-extracellular matrix (ECM) interactions and play a role in tumor progression, pre-mRNA splicing and apoptosis. One such member, galectin-13, is a 139 amino acid protein that contains one galectin domain. Possessing lysophospholipase activity, galectin-13 exists as a disulfide-linked homodimer. Galectin-13 is suggested to have a developmental role in the placenta and may display immunobiological activity in feto-maternal blood-spaces. Screening for galectin-13 in maternal serum during the first trimester of pregnancy may serve as a diagnostic marker to predict preterm pre-eclampsia. Primary antibodies are available purified, or with a selection of fluorescent CF® dyes and other labels. CF® dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

Immunogen: Recombinant human Galectin-13 protein fragment (aa23-134) (exact sequence is proprietary)

Klon: PP13-1162

Isotyp: IgG2b

Anwendungsinformationen

Applikationshinweise: Immunohistology (formalin) 0.5-1 μg/mL

• Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM Tris, 1 mM EDTA  pH 9.0 or 10 mM citrate buffer  pH 6.0 for 10-20 min followed by cooling at RT for 20 min
• Immunofluorescence 0.5-1 μg/mL
• Flow Cytometry 0.5-1 μg/million cells/0.1 mL
• ELISA For coating, order Ab without BSA
• Optimal dilution for a specific application should be determined by user

Kommentare:

K-562 cells. Placenta or Spleen.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 100 μg/mL

Buffer: PBS/0.1 % BSA/0.05 % azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Details zu LGALS13

Target: LGALS13 (Lectin, Galactoside-Binding, Soluble, 13 (LGALS13))

Andere Bezeichnung: Galectin-13 / Placental-Protein-13 (LGALS13 Produkte)

Synonyme: GAL13 antikoerper, PLAC8 antikoerper, PP13 antikoerper, Gal-11 antikoerper, Gal-13 antikoerper, Gal11 antikoerper, gal-13 antikoerper, galectin 13 antikoerper, avian beta-defensin 13 antikoerper, LGALS13 antikoerper, AvBD13 antikoerper

Hintergrund: Gal-13, GAL13, Galactoside-binding soluble lectin 13, Galectin-13, Galectin13, Lectin galactoside binding soluble 13, LGALS13, PLAC8, Placental protein 13 (PP13), Placental tissue protein 13

Molekulargewicht: 16 kDa (monomer), 32 kDa (homodimer)

Gen-ID: 29124, 23671

UniProt: Q9UHV8